Worldwide Healthcare Trust PLC - Annual Financial Report PR Newswire LONDON, United Kingdom, June 11 10 June 2025Worldwide Healthcare Trust PLC(the "Company") Annual Financial ...

Vertex Pharmaceuticals Inc. Annual cash flow by MarketWatch. View VRTX net cash flow, operating cash flow, operating expenses and cash dividends.

Here are some of the largest recent moves: CAPITAL RESEARCH GLOBAL INVESTORS added 4,107,393 shares (+39.4%) to their portfolio in Q1 2025, for an estimated $1,991,346,274; ALLIANCEBERNSTEIN L.P ...

Vertex posted first-quarter adjusted earnings per share of $4.06, with revenue rising 3% year-over-year to $2.77 billion. Analysts surveyed by Visible Alpha were looking for $4.19 and $2.83 ...

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) were sinking 11.9% as of 10:18 a.m. ET on Tuesday. Vertex reported Q1 revenue of $2.77 billion, up 3% year over year. In addition, Vertex revealed ...

Vertex Pharmaceuticals shares gained 0.5% to close at $501.15 on Friday. Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page.

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals (NASDAQ: VRTX). Compared to the S&P 500 index, which is down about ...

The new trading symbol “TNFA” replaces the Company’s previous trading symbol “MYMD” and coincides with the Company’s previously announced corporate name change to TNF Pharmaceuticals, Inc.